Whereas O. majorana-treated BPH groups showed a significant reduction in the cellular DNA damage marker (8-OH-dG) and significantly increased cellular antioxidant status measured by CAT and TAC compared to BPH (model) (Figure 3A–C). Here, CAT is linked to benign prostatic hyperplasia.